Phosphorylation of nuclear receptors: Novelty and therapeutic implications.
DNA-binding domain
Ligand-binding domain
Nuclear receptor
Phosphorylation
Transcription
Journal
Pharmacology & therapeutics
ISSN: 1879-016X
Titre abrégé: Pharmacol Ther
Pays: England
ID NLM: 7905840
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
01
03
2023
revised:
20
05
2023
accepted:
06
06
2023
medline:
14
7
2023
pubmed:
18
6
2023
entrez:
17
6
2023
Statut:
ppublish
Résumé
Nuclear receptors (NR) collectively regulate several biological functions in various organs. While NRs can be characterized by activation of the transcription of their signature genes, they also have other diverse roles. Although most NRs are directly activated by ligand binding, which induces cascades of events leading to gene transcription, some NRs are also phosphorylated. Despite extensive investigations, primarily focusing on unique phosphorylation of amino acid residues in different NRs, the role of phosphorylation in the biological activity of NRs in vivo has not been firmly established. Recent studies on the phosphorylation of conserved phosphorylation motifs within the DNA- and ligand-binding domains confirmed has indicated the physiologically relevance of NR phosphorylation. This review focuses on estrogen and androgen receptors, and highlights the concept of phosphorylation as a drug target.
Identifiants
pubmed: 37330113
pii: S0163-7258(23)00141-9
doi: 10.1016/j.pharmthera.2023.108477
pii:
doi:
Substances chimiques
Ligands
0
Receptors, Cytoplasmic and Nuclear
0
DNA-Binding Proteins
0
DNA
9007-49-2
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108477Informations de copyright
Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that there are no conflicts of interest.